These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26854932)

  • 1. Longitudinal measures of cognition in the Ts65Dn mouse: Refining windows and defining modalities for therapeutic intervention in Down syndrome.
    Olmos-Serrano JL; Tyler WA; Cabral HJ; Haydar TF
    Exp Neurol; 2016 May; 279():40-56. PubMed ID: 26854932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model.
    Stringer M; Abeysekera I; Dria KJ; Roper RJ; Goodlett CR
    Pharmacol Biochem Behav; 2015 Nov; 138():70-9. PubMed ID: 26363314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.
    Granholm AC; Sanders LA; Crnic LS
    Exp Neurol; 2000 Feb; 161(2):647-63. PubMed ID: 10686084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome.
    Rueda N; Flórez J; Martínez-Cué C
    Behav Brain Res; 2008 Apr; 188(2):355-67. PubMed ID: 18178265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome.
    Heinen M; Hettich MM; Ryan DP; Schnell S; Paesler K; Ehninger D
    Neural Plast; 2012; 2012():467251. PubMed ID: 22848851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience-dependent reduction of soluble β-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome.
    Sansevero G; Begenisic T; Mainardi M; Sale A
    Exp Neurol; 2016 Sep; 283(Pt A):49-56. PubMed ID: 27288239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.
    Faizi M; Bader PL; Tun C; Encarnacion A; Kleschevnikov A; Belichenko P; Saw N; Priestley M; Tsien RW; Mobley WC; Shamloo M
    Neurobiol Dis; 2011 Aug; 43(2):397-413. PubMed ID: 21527343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome.
    Sago H; Carlson EJ; Smith DJ; Rubin EM; Crnic LS; Huang TT; Epstein CJ
    Pediatr Res; 2000 Nov; 48(5):606-13. PubMed ID: 11044479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nest building is impaired in the Ts65Dn mouse model of Down syndrome and rescued by blocking 5HT2a receptors.
    Heller HC; Salehi A; Chuluun B; Das D; Lin B; Moghadam S; Garner CC; Colas D
    Neurobiol Learn Mem; 2014 Dec; 116():162-71. PubMed ID: 25463650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid forgetting of social learning in the Ts65Dn mouse model of Down syndrome: New evidence for hippocampal dysfunction.
    Powers BE; Santiago NA; Strupp BJ
    Behav Neurosci; 2018 Feb; 132(1):51-56. PubMed ID: 29553775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome.
    Martínez-Cué C; Rueda N; García E; Davisson MT; Schmidt C; Flórez J
    Behav Brain Res; 2005 Sep; 163(2):174-85. PubMed ID: 15941601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome.
    Rueda N; Flórez J; Martínez-Cué C
    Neurosci Lett; 2008 Mar; 433(1):22-7. PubMed ID: 18226451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities.
    Leach PT; Crawley JN
    Genes Brain Behav; 2018 Jul; 17(6):e12452. PubMed ID: 29266714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age exacerbates abnormal protein expression in a mouse model of Down syndrome.
    Ahmed MM; Block A; Tong S; Davisson MT; Gardiner KJ
    Neurobiol Aging; 2017 Sep; 57():120-132. PubMed ID: 28641136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term running alleviates some behavioral and molecular abnormalities in Down syndrome mouse model Ts65Dn.
    Kida E; Rabe A; Walus M; Albertini G; Golabek AA
    Exp Neurol; 2013 Feb; 240():178-89. PubMed ID: 23201095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen.
    Hunter CL; Bimonte-Nelson HA; Nelson M; Eckman CB; Granholm AC
    Neurobiol Aging; 2004 Aug; 25(7):873-84. PubMed ID: 15212841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome.
    Shichiri M; Yoshida Y; Ishida N; Hagihara Y; Iwahashi H; Tamai H; Niki E
    Free Radic Biol Med; 2011 Jun; 50(12):1801-11. PubMed ID: 21447382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Working memory in the aged Ts65Dn mouse, a model for Down syndrome.
    Whitney KN; Wenger GR
    Behav Brain Res; 2012 Jun; 232(1):202-9. PubMed ID: 22503781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease.
    Hyde LA; Crnic LS
    Behav Neurosci; 2001 Dec; 115(6):1239-46. PubMed ID: 11770055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    O'Leary TP; Brown RE
    Behav Brain Res; 2009 Jul; 201(1):120-7. PubMed ID: 19428625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.